Biotechnology firm based by Turkish scientists Uğur Şahin and Özlem Türeci BioNTech US pharmaceutical firm PfizerThe brand new efficacy charge of the coronavirus vaccine developed by .
towards the coronavirus 95.3 p.c reported to be efficient BioNTech/Pfizer coronavirus vaccine The research, which has been carried out on 44 thousand folks since final November, has revealed the final degree of effectiveness of the vaccine. Accordingly, BioNTech/Pfizer coronavirus vaccine towards SARS-COV-2 virus 91.3 p.c efficient.
In keeping with the statements in regards to the vaccine, the BioNTech/Pfizer coronavirus vaccine, at the least six months safety offers. It will also be used towards the South African variant of the vaccine known as B.1.351. 100% safety Nonetheless, allow us to underline that the information in query was obtained from a small pattern of 800 folks.
Pfizer’s Chief Government Officer, Albert Bourla, mentioned in a press release on the topic that the up to date outcomes, which embody knowledge on greater than 12,000 individuals who had acquired two doses for at the least six months, shall be submitted for US authorized approval. whereas expressing BioNTech CEO Uğur Şahin additionally spoke in regards to the topic as follows:
“Preliminary scientific outcomes point out that the vaccine can successfully shield (people) towards circulating variants. That is to realize herd immunity and ending this epidemic for the worldwide inhabitants is a essential issue for
Dikkat: Sitemiz herkese açık bir platform olduğundan, çox fazla kişi paylaşım yapmaktadır. Sitenizden izinsiz paylaşım yapılması durumunda iletişim bölümünden bildirmeniz yeterlidir.
Kaynak: https://www.webtekno.com/biontech-pfizer-asisi-yeni-etkinlik-orani-h108223.html
